S5 Ep26: FDA Approval Insights: Sacituzumab Govitecan in Urothelial Cancer
OncLive® On Air - En podcast av OncLive® On Air
Dr. Tagawa discusses the FDA approval of sacituzumab govitecan in urothelial cancer, key efficacy and safety data from the pivotal TROPHY-U-01 trial, and expectations for the confirmatory TROPiCS-04 trial.
